FLT-3 (FMS-like tyrosine kinase-3) receptor kinase is one of the targets of midostaurin, and its mutations are frequently found in acute myeloid leukemia (AML), which result in the constitutive activation of FLT-3 and induce cell proliferation [8]. Here, FLT3 is linked to acute myeloid leukemia.